Company: ARVN
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001655759-25-000103
Chunk: 2

Company: ARVINAS, INC.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 8.01
Chunk 2
---
This Current Report on Form 8-K contains forward-looking statements that involve substantial risks and uncertainties, including statements regarding these preclinical data potentially suggesting the broad utility of ARV-393 across non-Hodgkin lymphoma subtypes with unmet need beyond DLBCL and providing a compelling rationale for considering combination strategies including chemotherapy-free approaches. All statements, other than statements of historical facts, contained in this Current Report on Form 8-K, including statements regarding the Company’s strategy, future operations, prospects, plans and objectives of management, are forward-looking statements. The words "believe," and "potentially,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements the Company makes as a result of various risks and uncertainties, including the important factors discussed the important factors discussed in the “ Risk Factors” sections contained in the Company’s quarterly and annual reports on file with the U. S. Securities and Exchange Commission. The forward-looking statements contained in this Current Report on Form 8-K reflect the Company’s current views with respect to future events, and the Company assumes no obligation to update any forward-looking statements except as required by applicable law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.